Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Micro-X Ltd. ( (AU:MX1) ) has shared an update.
Micro-X reported steady operational and commercial progress for the March 2026 quarter, highlighting growing market interest in its upgraded Rover 2026 mobile X-ray model, particularly following its debut at a major radiology conference. The new Rover features, including an improved detector, integrated charging and a streamlined chassis, are supporting deeper engagement with commercial and government customers, especially in Asian markets where healthcare providers are upgrading diagnostic capacity.
On the development side, Micro-X installed and commissioned its first Head CT test bench at Royal Melbourne Hospital, a leading stroke centre, and completed a full body laboratory test bench that unlocked a $1.6 million milestone payment, alongside a further milestone from its security-focused baggage scanner program. The Head CT clinical pilot, run with the Australian Stroke Alliance across two major hospitals, is designed to generate comparative imaging data from 108 patients over about six months, underpinning regulatory submissions targeted for 2027 and laying the groundwork for commercial launch.
Financially, the company recorded $0.9 million in customer receipts from product sales and completed a capital placement that added $1.6 million, finishing the quarter with $3.5 million in cash plus expected tax incentives and receivables that further bolster liquidity. Management acknowledged slower-than-expected progress in monetising the security business but indicated that this remains a strategic priority, with ongoing discussions at industry forums pointing to potential future partnering or commercialisation pathways for its security technology.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.16 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Ltd is an Australian hi-tech manufacturer specialising in cold cathode X-ray technology for global health and security markets. Its core products include the Rover mobile X-ray system and innovative imaging platforms such as a miniaturised Head CT scanner, with a market focus on hospitals, diagnostic providers and security screening applications worldwide.
Average Trading Volume: 355,130
Technical Sentiment Signal: Sell
Current Market Cap: A$42.29M
For a thorough assessment of MX1 stock, go to TipRanks’ Stock Analysis page.